Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide
- PMID: 7562053
Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide
Abstract
A 49-yr-old white woman with diffuse sclerosing variant of papillary carcinoma of the thyroid revealed abnormal [18F]FDG accumulation within cervical lymph node metastases prior to thyroidectomy. The abnormal cervical foci of glucose metabolism corresponded to similar areas of abnormal [99mTc]pertechnetate and radioiodine accumulation on presurgical scans. The primary thyroid tumor within the thyroid gland was not delineated as a focal defect on any of the three imaging studies. The relative thyroid-to-background soft-tissue ratio in the [18F]FDG study, however, appeared higher than usual. As with 131I and [99mTc]pertechnetate, this case demonstrates that [18F]FDG PET can detect cervical lymph node metastases in the preoperative thyroid cancer patient.
Similar articles
-
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.J Nucl Med. 1999 Jun;40(6):986-92. J Nucl Med. 1999. PMID: 10452315
-
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.J Nucl Med. 1996 Sep;37(9):1468-72. J Nucl Med. 1996. PMID: 8790195
-
Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.Anticancer Res. 2003 May-Jun;23(3C):2973-6. Anticancer Res. 2003. PMID: 12926147 Clinical Trial.
-
Papillary thyroid carcinoma concentrating both Tc-99m sodium pertechnetate and I-131 iodide. Case report and review of the literature.Clin Nucl Med. 1991 Jul;16(7):497-500. doi: 10.1097/00003072-199107000-00008. Clin Nucl Med. 1991. PMID: 1657482 Review.
-
Pancreatic metastasis from papillary thyroid carcinoma: Case report and literature review.Hell J Nucl Med. 2021 May-Aug;24(2):140-148. doi: 10.1967/s002449912354. Epub 2021 Aug 6. Hell J Nucl Med. 2021. PMID: 34352049 Review.
Cited by
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.Eur J Nucl Med. 1996 Mar;23(3):312-9. doi: 10.1007/BF00837630. Eur J Nucl Med. 1996. PMID: 8599963
-
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.Eur Radiol. 2007 Dec;17(12):3139-47. doi: 10.1007/s00330-007-0682-2. Epub 2007 May 22. Eur Radiol. 2007. PMID: 18004607
-
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.Eur J Nucl Med. 1996 Dec;23(12):1641-74. doi: 10.1007/BF01249629. Eur J Nucl Med. 1996. PMID: 8929320 Review.
-
Diagnostic accuracy of single-source dual-energy computed tomography and ultrasonography for detection of lateral cervical lymph node metastases of papillary thyroid carcinoma.J Thorac Dis. 2019 Dec;11(12):5032-5041. doi: 10.21037/jtd.2019.12.45. J Thorac Dis. 2019. PMID: 32030219 Free PMC article.
-
Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.Endocr Pathol. 2005 Winter;16(4):331-48. doi: 10.1385/ep:16:4:331. Endocr Pathol. 2005. PMID: 16627920
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials